The Medscape Journal of Medicine Psychiatry

• The A, B, C's of Factitious Disorder: A Response to Turner Factitious disorder has been given little attention in the preparation of the DSM-V. This paper rejects a published reformulation of the disorder and offers a reconceptualization of the diagnosis.
  The Medscape Journal of Medicine, January 2009
• Assessing Behavioral Coping Preferences of Psychiatric Inpatients: A Pilot Study Inpatients' preferences for preventing loss of control differ by diagnosis, sex, age, and ethnicity. Individual preferences can be used to develop optimal case management strategies.
  The Medscape Journal of Medicine, December 2008
• Publication Bias and the Pharmaceutical Industry: The Case of Lamotrigine in Bipolar Disorder Negative unpublished data on lamotrigine provide an important context for clinical practice and research and raise concerns about access to studies showing inefficacy of psychotropic medications.
  The Medscape Journal of Medicine, September 2008
• Factitious Usher Syndrome: A New Type of Factitious Disorder A 51-year-old woman feigns a genetic form of deafblindness with no apparent external gain.
  The Medscape Journal of Medicine, June 2008
• Abuse of Medications Employed for the Treatment of ADHD: Results From a Large-Scale Community Survey This article evaluates prescription and illicit stimulant abuse in the treatment of ADHD. The results suggest that long-acting stimulants may have lower abuse potential than short-acting agents.
  The Medscape Journal of Medicine, May 2008
• Improved Mood and Remission of Symptoms in Long-term Major Depression Using Vagus Nerve Stimulation The study reports results seen with a patient, including her response to traditional antidepressants and the positive results seen using vagus nerve stimulation therapy.
  Medscape General Medicine, December 2007
• The Effects of Attention-Deficit/Hyperactivity Disorder on Employment and Household Income This article evaluates ADHD's impact on individual employment and income and quantifies costs of ADHD on workforce productivity for the US population.
  Medscape General Medicine, July 2006
• Understanding the Needs of Lesbian, Gay, Bisexual, and Transgender People Living With Mental Illness Often clinicians make the mistake of assuming a client is heterosexual. Find out how LGBT clients differ from heterosexual clients, and learn 6 things you can do to provide inclusive care.
  Medscape General Medicine, May 2006
• The Clinical History and Costs Associated With Delayed Diagnosis of Bipolar Disorder How does delayed diagnosis vary by age, race, or gender? How does it affect healthcare utilization before diagnosis? To what extent is it associated with additional costs after diagnosis?
  Medscape General Medicine, April 2006
• Self-Help and Serious Mental Illness What is self-help? What evidence is there that self-help benefits people with serious mental illness? How and why does it work? What self-help groups are available?
  Medscape General Medicine, March 2006
• Does the Use of an Automated Tool for Self-Reporting Mood by Patients With Bipolar Disorder Bias the Collected Data? Automation of data collection from patients can potentially improve data quality, enhance adherence, and decrease costs in longitudinal studies -- but is there bias in automated self-report?
  Medscape General Medicine, August 2005
• Venlafaxine and Serious Withdrawal Symptoms: Warning to Drivers What do you need to know if you prescribe this popular medication?
  Medscape General Medicine, July 2005
• Promotional Talks for the Pharmaceutical Industry Thomas A. M. Kramer, MD, offers his view on the new requirements surrounding promotional talks for the pharmaceutical industry.
  Medscape General Medicine, July 2004
• Psychopharmacology in The New York Times Thomas A. M. Kramer, MD, discusses some of the topical psychopharmacology articles recently covered in The New York Times.
  Medscape General Medicine, June 2004
• On Female Physicians Committing Suicide Physician suicide is an important topic; the suicide rate for female physicians is 4 times the national female rate.
  Medscape General Medicine, May 2004
• Cognitive Effects of Olanzapine Treatment in Schizophrenia The vast majority of individuals with schizophrenia have significant impairment in most domains of cognitive functioning. Data suggest that olanzapine improved some of these cognitive deficits.
  Medscape General Medicine, May 2004
• All the Things They Taught Us That Were Wrong This column seeks to debunk the many myths of psychopharmacology.
  Medscape General Medicine, May 2004
• Psychiatry Guest Editor's Column -- International Consensus Group on Bipolar I Depression Treatment Guidelines: Synopsis and Discussion* New treatment guidelines for bipolar depression
  Medscape General Medicine, April 2004
• Talking Points About Antidepressants and Suicide It is important to describe the issues surrounding antidepressants and suicide in context.
  Medscape General Medicine, April 2004
• Should Older Adults Be Screened for Cognitive Impairment? Cognitive screening for the elderly
  Medscape General Medicine, March 2004